Hematology Prof. Dr. Meliha Nalçacı
✓ Medically verified profileProf. Dr. Meliha Nalçacı
✓ Medically verified profile
Quick answer
Prof. Dr. Meliha Nalçacı is a hematology specialist at Acıbadem Bakırköy Hospital. She evaluates and manages blood-related conditions through the hospital’s Hematology Unit, drawing on an academic and clinical career in internal medicine and hematology at İstanbul University İstanbul Faculty of Medicine.
About Prof. Dr. Meliha Nalçacı
Prof. Dr. Meliha Nalçacı is a hematology specialist at Acıbadem Bakırköy Hospital, providing assessment and care for patients with blood-related conditions.
She completed her medical education at İstanbul University İstanbul Faculty of Medicine in 1980. Her training and academic career at the same faculty included Internal Medicine, Hematology, research assistantship, associate professorship, and professorship.
International patients can expect hematology consultations informed by her long-standing academic and clinical background, with care coordinated through the Hematology Unit at Acıbadem Bakırköy Hospital.
Areas of Expertise
Conditions treated and procedures performed by this specialist.
Education
- 1999İstanbul University İstanbul Faculty of Medicine / Professor
- 1994İstanbul University İstanbul Faculty of Medicine Hematology
- 1993–1999İstanbul University İstanbul Faculty of Medicine Department of Internal Medicine, Department of Internal Medical Sciences / Associate Professor
- 1987–1993İstanbul University İstanbul Faculty of Medicine Department of Internal Medicine, Department of Internal Medical Sciences / Research Assistant
- 1984İstanbul University İstanbul Faculty of Medicine Internal Medicine
- 1980İstanbul University İstanbul Faculty of Medicine
Professional Experience
- 2025Acıbadem Healthcare Services
Selected Publications
- transfusion of blood and blood products . clinical actual medicine internal medicine forum, 5(2), 55-61. (Control No: 4616984) NALÇACI MELİHA
- The frequency of C609T polymorphism in the NQ01 gene and its relation to cytogenetic abnormalities in patients with myelodysplastic syndrome celi mol biol, 30 (Publication No: 3213229) bağatır gülçin,SIRMA EKMEKÇİ SEMA,palandüz şükrü,ÖZTÜRK ŞÜKRÜ,ÇEFLE KIVANÇ,ÖZBEK UĞUR,YENEREL MUSTAFA NURİ,NALÇACI MELİHA
- The Clinical Significance of IDH Mutations in Essential Thrombocythemia and Primary Myelofibrosis j elin med res, 8(1), 29- 39. (Publication No: 3213584) diral turkeys silk,mountains aday aynur,turkeys fehmi,akadam teker başak,yılmaz ceylan,NALÇACI MELİHA,YAVUZ AKİF SELİM,SARGIN FATMA DENİZ
- Rituximab Therapy in Adults with Refractory Symptomatic Immune Thrombocytopenia Long Term Follovv Up of 15 Cases turk j haematol, Doi: 10.4274/tjh.2016.0086 (Publication No: 3213301) turkeys fehmi,diral turkeys silk,YENEREL MUSTAFA NURİ,NALÇACI MELİHA,KÜÇÜKKAYA REYHAN
- Impact of JAK2V617F Mutational Status on Phenotypic Features in Essential Thrombocythemia and Primary Myelofibrosis turk j haematol, 5(33), 94-101. (Publication No: 3213685) diral ipek,dağlar aday aynur,akadam teker başak,yılmaz ceylan,NALÇACI MELİHA,YAVUZ AKİF SELİM,SARGIN FATMA DENİZ
- The Burden of JAK2V617F Mutated Allele in Turkish Patients With Myeloproliferative Neoplasms. J Clin Med Res, 7(3), 161-170. (Publication No: 1836377) silk from yonal turkeys,dağlar aday aynur,akadam teker basak.yılmaz ceylan,NALÇACI MELİHA,YAVUZ AKİF SELİM,SARGIN FATMA DENİZ
- Prognostic significance of ASXL1 JAK2V617F mutations and JAK2V617F allele burden in Philadelphia negative myeloproliferative neoplasms J Blood Med, 6, 157-171., Doi: doi: 10.2147/JBM.S78826. eCollection 2015. (Publication No: 1835326) silk from yonal turkeys,dağlar aday aynur,akadam teker basak.yılmaz ceylan,NALÇACI MELİHA,yavuz akif selim,sargın deniz
- MPL W515L K Mutations in Chronic Myeloproliferative Neoplasms TURK J HEMATOL, 30(1), 8-12. (Publication No: 1836709) AKPINAR TİMUR SELÇUK,HANÇER VEYSEL SABRİ,NALÇACI MELİHA,DİZ KÜÇÜKKAYA REYHAN
- Revievv of therapeutic options and the management of patients with myelodysplastic syndromes. EXPERT REV HEMATOL, 6(2), 165-189. (Publication No: 1836883) ÖZCAN MEHMET ALİ,İLHAN OSMAN,ÖZCEBE OSMAN İLHAMİ,NALÇACI MELİHA,GÜLBAŞ ZAFER
Frequently Asked Questions
What is Dr. Meliha Nalçacı's specialty?
Which hospital does Dr. Meliha Nalçacı practise at?
What languages can I use when consulting Dr. Meliha Nalçacı?
How can I book an appointment with Dr. Meliha Nalçacı?
Is an online video consultation available with Dr. Meliha Nalçacı?
How many years of experience does Dr. Meliha Nalçacı have?
Can international patients arrange treatment with Dr. Meliha Nalçacı?
How do I get a second opinion involving Dr. Meliha Nalçacı?
A dedicated team, from first message to follow-up
Our international patient office coordinates your appointment, travel and treatment across the Acıbadem network — including 7 JCI-accredited hospitals — and stays with you in your own language, every step of the way.
Schedule your appointment with Prof. Dr. Meliha Nalçacı
Choose a date and time that suits you. Our international patient team will check availability and confirm your appointment — usually within 24 hours.
- 1Choose your date & timePick a preferred day and time slot for your visit.
- 2Share your detailsTell us how to reach you and anything we should know.
- 3We confirm with youOur team confirms the appointment by phone or email.
Request your appointment
This request goes directly to this doctor’s schedule.
Your information stays strictly confidential and is used only to arrange your care.
Hospitals
Medical Units
What patients say about Prof. Dr. Meliha Nalçacı
★★★★★From 2,400+ verified patient reviews“I travelled from abroad for anemia treatment and the whole experience was seamless. Prof. Dr. Nalçacı explained the risks honestly and earned my full trust. The international patient office coordinated everything perfectly.”
“Facing a blood cancer diagnosis, I found Prof. Dr. Nalçacı honest, knowledgeable and deeply reassuring.”